Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coleman

Showing results (771-780 of 1,064) with videos related to

Pageof 107
Sort By:
Journal of Visualized Experiments : Jove|February 1, 2021
Building a Simple and Versatile Illumination System for Optogenetic ExperimentsPhillip Kyriakakis, Lourdes Fernandez de Cossio, Patrick Wade Howard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Cancer survival increases in Europe, but international differences remain wideM Sant, R Capocaccia, M P Coleman, et al.
Brain : a Journal of Neurology|January 13, 2005
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy miceWeiqian Mi, Bogdan Beirowski, Thomas H Gillingwater, et al.
ALTEX|May 25, 2017
From in vivo to in vitro: The medical device testing paradigm shiftDayna Kerecman Myers, Alan M Goldberg, Albrecht Poth, et al.
Journal of Clinical Epidemiology|July 27, 2001
Coffee consumption and serum aminotransferases in middle-aged Japanese menS Honjo, S Kono, M P Coleman, et al.
ACS Synthetic Biology|January 5, 2018
Biosynthesis of Orthogonal Molecules Using Ferredoxin and Ferredoxin-NADP<sup>+</sup> Reductase Systems Enables Genetically Encoded PhyB OptogeneticsPhillip Kyriakakis, Marianne Catanho, Nicole Hoffner, et al.
The European Journal of Neuroscience|January 19, 2005
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapsesRobert Adalbert, Thomas H Gillingwater, Jane E Haley, et al.
Neurobiology of Disease|November 20, 2019
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degenerationAndrea Loreto, Ciaran S Hill, Victoria L Hewitt, et al.
Current Biology : CB|March 7, 2017
NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In VivoMichele Di Stefano, Andrea Loreto, Giuseppe Orsomando, et al.
Cell Death and Differentiation|April 29, 2006
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degenerationL Conforti, G Fang, B Beirowski, et al.
Pageof 107

Showing results (771-780 of 1,064) with videos related to

Sort By:
Pageof 107
Journal of Visualized Experiments : Jove|February 1, 2021
Building a Simple and Versatile Illumination System for Optogenetic ExperimentsPhillip Kyriakakis, Lourdes Fernandez de Cossio, Patrick Wade Howard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Cancer survival increases in Europe, but international differences remain wideM Sant, R Capocaccia, M P Coleman, et al.
Brain : a Journal of Neurology|January 13, 2005
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy miceWeiqian Mi, Bogdan Beirowski, Thomas H Gillingwater, et al.
ALTEX|May 25, 2017
From in vivo to in vitro: The medical device testing paradigm shiftDayna Kerecman Myers, Alan M Goldberg, Albrecht Poth, et al.
Journal of Clinical Epidemiology|July 27, 2001
Coffee consumption and serum aminotransferases in middle-aged Japanese menS Honjo, S Kono, M P Coleman, et al.
ACS Synthetic Biology|January 5, 2018
Biosynthesis of Orthogonal Molecules Using Ferredoxin and Ferredoxin-NADP<sup>+</sup> Reductase Systems Enables Genetically Encoded PhyB OptogeneticsPhillip Kyriakakis, Marianne Catanho, Nicole Hoffner, et al.
The European Journal of Neuroscience|January 19, 2005
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapsesRobert Adalbert, Thomas H Gillingwater, Jane E Haley, et al.
Neurobiology of Disease|November 20, 2019
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degenerationAndrea Loreto, Ciaran S Hill, Victoria L Hewitt, et al.
Current Biology : CB|March 7, 2017
NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In VivoMichele Di Stefano, Andrea Loreto, Giuseppe Orsomando, et al.
Cell Death and Differentiation|April 29, 2006
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degenerationL Conforti, G Fang, B Beirowski, et al.
Pageof 107